1. To understand the current therapeutic landscape of hormonal therapies for metastatic prostate cancer

2. To become familiar with the potential mechanisms of resistance to androgen receptor targeted therapies

3. To understand how the glucocorticoid receptor may targeted in prostate cancer


Session date: 
08/28/2017 - 12:00pm to 1:00pm CDT
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Russell Szmulewitz, MD